CTAD Notebook: Novo Explains Semaglutide Alzheimer’s Rationale, Roche’s Trontinemab Update

 
• By Mandy Jackson
  
Semaglutide did not work in Alzheimer's disease, but trontinemab reduces amyloid plaques (Shutterstock)

More from Neurological

More from Scrip